Invention Grant
- Patent Title: AIDS virus vaccines using Sendai virus vector
- Patent Title (中): 艾滋病病毒疫苗使用仙台病毒载体
-
Application No.: US12701303Application Date: 2010-02-05
-
Publication No.: US08217019B2Publication Date: 2012-07-10
- Inventor: Munehide Kano , Tetsuro Matano , Atsushi Kato , Yoshiyuki Nagai , Mamoru Hasegawa
- Applicant: Munehide Kano , Tetsuro Matano , Atsushi Kato , Yoshiyuki Nagai , Mamoru Hasegawa
- Applicant Address: JP Ibaraki JP Tokyo
- Assignee: DNAVEC Research Inc.,Japan as Represented by the Director General of National Institute of Infectious Disease
- Current Assignee: DNAVEC Research Inc.,Japan as Represented by the Director General of National Institute of Infectious Disease
- Current Assignee Address: JP Ibaraki JP Tokyo
- Agency: Clark & Elbing LLP
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/74 ; A01N63/00

Abstract:
The present invention provides a vaccine containing a Sendai virus vector encoding a virus protein of an immunodeficiency virus. By intranasally administering a Sendai virus encoding a virus protein of an immunodeficiency virus to a macaque monkey, the present inventors have succeeded in efficiently inducing protective immunity against an immunodeficiency virus. As a result of intranasal inoculation of vaccine, expression of an antigen protein mediated by Sendai virus vector was detected in intranasal mucous membrane and local lymph nodes and antigen-specific cellular immune response was induced at a significant level. No pathological symptom by vaccination was observed. After vaccination, exposure of simian immunodeficiency virus was performed and the effect was examined. As a result, the amount of virus in plasma significantly decreased, compared with that of the control animal. The present invention provides a promising vaccine as an AIDS vaccine.
Public/Granted literature
- US20100266633A1 AIDS VIRUS VACCINES USING SENDAI VIRUS VECTOR Public/Granted day:2010-10-21
Information query